DEA Proposes New Regulation Quotas For Opioid Manufacturers

The DEA has proposed new regulations to limit excess medication quantities to combat the opioid epidemic. These regulations introduce new quota types for manufacturers, affecting drug packaging and chemical acquisition. This announcement follows a DOJ report criticizing the DEA's slow response to the opioid crisis, highlighting a 400% increase in oxycodone quotas from 2002 to 2013. The public has 60 days to comment on these regulations. The CDC reports an average of 130 opioid overdose deaths daily.

What new insight or understanding did you gain from this video?